Meropenem
A thienamycin derivative antibacterial agent that is more stable to renal dehydropeptidase I than IMIPENEM, but does not need to be given with an enzyme inhibitor such as CILASTATIN. It is used in the treatment of bacterial infections, including infections in immunocompromised patients.
Year introduced: 2019 (1989)
PubMed search builder options
Subheadings:
Tree Number(s): D02.065.589.099.124.300.750, D03.633.100.300.124.300.750
MeSH Unique ID: D000077731
Registry Number: FV9J3JU8B1
Entry Terms:
- Merrem
- SM 7338
- SM-7338
- SM7338
- Ronem
- Penem
- 3-(5-Dimethylcarbamoylpyrrolidin-3-ylthio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid
Pharmacologic Action: